![Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study | BMC Endocrine Disorders Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study | BMC Endocrine Disorders](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12902-016-0149-z/MediaObjects/12902_2016_149_Fig2_HTML.gif)
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study | BMC Endocrine Disorders
![Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40618-018-0991-0/MediaObjects/40618_2018_991_Fig1_HTML.png)
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
![Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-020-00367-2/MediaObjects/41581_2020_367_Fig1_HTML.png)
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology
![The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-018-0704-1/MediaObjects/12933_2018_704_Fig2_HTML.gif)
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
![Continued) Oral diabetes medications: mechanism of action, side effects. | Download Scientific Diagram Continued) Oral diabetes medications: mechanism of action, side effects. | Download Scientific Diagram](https://www.researchgate.net/profile/Alyson-Myers-4/publication/322237224/figure/tbl3/AS:1045262256582657@1626221350625/Continued-Oral-diabetes-medications-mechanism-of-action-side-effects.png)
Continued) Oral diabetes medications: mechanism of action, side effects. | Download Scientific Diagram
![Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3541863/bin/PTJ3712699-f1.jpg)
Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig2_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ba41cf6e-4ccf-4587-8bea-2c4f2127d23a/jdb12439-fig-0002-m.jpg)
The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library
![Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6c0cc798-ad83-404c-8d17-55c9b30e5724/gr1_lrg.jpg)
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism
![Sitagliptin for type 2 diabetes mellitus | DPP 4 inhibitor | Mechanism, precautions & side effects - YouTube Sitagliptin for type 2 diabetes mellitus | DPP 4 inhibitor | Mechanism, precautions & side effects - YouTube](https://i.ytimg.com/vi/xAWCneDnfso/maxresdefault.jpg)
Sitagliptin for type 2 diabetes mellitus | DPP 4 inhibitor | Mechanism, precautions & side effects - YouTube
![Cardiovascular effects of sitagliptin – An anti‐diabetes medicine - Zhou - 2018 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library Cardiovascular effects of sitagliptin – An anti‐diabetes medicine - Zhou - 2018 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4d8ecd1a-584a-4520-be0d-f59173ccd63a/cep12953-fig-0001-m.jpg)
Cardiovascular effects of sitagliptin – An anti‐diabetes medicine - Zhou - 2018 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
![Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram](https://www.researchgate.net/profile/Iqbal-Malik/publication/23304097/figure/fig2/AS:310188415438849@1450966089391/Mechanism-of-action-of-sitagliptin-vildagliptin-and-exenatide-GLP-1-is-released-from-L.png)
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
![Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9268d3a9-5c5a-4d5a-9315-192ffb3aa9b5/cam43024-fig-0006-m.jpg)
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)